Although most multiple myeloma mm cases are characterized by the detection of a monoclonal immunoglobulin in the serum, about 15% of the patients present only immunoglobulin light chains, detected either in the urine or serum or both. Clinical analysis of cardiac involvement in 53 patients with. Accordingly, the international myeloma working group added a more stringent response category, stringent complete response scr, which in addition to meeting the conventional cr criteria. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of. Normally, they are present in equal amounts in the blood, giving a ratio of 1 to 1. Sharply increased serum free lightchain concentrations. Kidney therapy for free light chain removal in patients. Lightchain only multiple myeloma is due to the absence of. Serumfree lightchain analysis in diagnosis and management.
Multiple myeloma is a form of cancer that afflicts human bone marrow and blood cells. Imwg criteria for the diagnosis of myeloma and guidelines for the diagnostic workup of myeloma criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies that are recommended by the working group for the diagnosis of myeloma and related organ dysfunction. Lcs are normally cleared by the kidneys, but in lcdd, these light chain deposits damage organs and cause disease. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
My blood draw results, and also the free light chain test, show that i am in the normal range for igg protein. If the myeloma cells are releasing kappa free light chains, the freelite test will show a high level of kappa light chain protein and a normal, or lower than normal, level of lambda light chains. In 2014, the international myeloma working group changed the diagnostic criteria for multiple myeloma to include biomarkers. If there is more of one type of light chain than the other, the ratio will be different, which can be a sign of myeloma. Jul 28, 2014 an exclusive production of light chains can be found in 15% of myeloma cases. People with lcdd make too many light chains, which get deposited in many body tissues. Imwg guidelines for serum free light chain analysis in multiple myeloma and related disorders. Clinical analysis of cardiac involvement in 53 patients. Utility of serum free light chain ratio in response. Bottom line in myeloma therapy in patients with multiple myeloma, the free light chain assay is important in predicting response to therapy and for predicting. Nine of ten living patients showed marked elevations of free serum lchains see table 1 predominantly of one major l chain type. Correlation of serum immunoglobulin free light chain quantification with urinary bence jones protein in light chain myeloma. Myeloma patients with sharp serum mcomponents also.
My husband was diagnosed in april 2010 with stage 3 lightchain multiple myeloma after several months of debilitating back and rib pain. Below are the diagnostic criteria for 3 of the most common plasma cell disorders. Myeloma patients with sharp serum mcomponents also showed free serum lchains and in 11%, concentrations of the same order of magnitude as was the case in the hypogammaglobulinemic patients. They only produce part of the immunoglobulin called the light chain.
Apr 03, 2020 multiple myeloma is a form of cancer that afflicts human bone marrow and blood cells. Multiple myeloma mm, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Hyperviscosity syndrome in association with kappa light chain. Light chain deposition disease lcdd is a rare condition characterized by the deposition of specific proteins monoclonal light chains in the kidneys and other organs. The treatment brought my counts down to almost normal so i. Nine of ten living patients showed marked elevations of free serum lchains see table 1 predominantly of one major lchain type. Case reports hyperviscosity syndrome in association with kappa light chain myeloma peter w. When the light chain is attached to the heavy chain, it is known as a. As many as 18 percent of all multiple myeloma cancer patients have the lightchain myeloma variety.
Multiple myeloma the path to diagnosis mymyelomateam. Prognostic value of serum free light chain in multiple myeloma article pdf available in the egyptian journal of immunology egyptian association of immunologists 222. There are different stages and varieties of this incurable form of cancer, and each one produces. These patients are designated as having light chain lc mm.
Light chains are used to make antibodies that the body needs to fight infection. I then had a stem cell transplant and had a complete response. Jan 01, 2010 increases in the flc concentration after treatment for mm may be due to a lightchain escape phenomenon, referred to as lightchain escape from plateau phase lepp. Durham, north carolina the hyperviscosity syndrome is a clinical emergen rally involving bleeding, retinal changes, andor neurologic signs and symptoms 1. Monoclonal gammopathy of undetermined significance. In al amyloidosis, abnormal plasma cells in the bone marrow produce proteins called light chains which are released into the bloodstream and go on to form amyloid deposits in the tissues and organs.
Oct 15, 2010 my husband was diagnosed in april 2010 with stage 3 light chain multiple myeloma after several months of debilitating back and rib pain. About 20 out of 100 people with myeloma 20% do not produce complete immunoglobulins. There are two types of immunoglobulin light chains, kappa. Lightchain multiple myeloma also appears to have a poorer prognosis than igg and iga subtypes when treated with chemotherapy. Nonsecretory and light chain escape in patients with. I have blood draws once a month and see my oncologist once a month to discuss the results of he blood draws. Light chain deposition disease lcdd is a rare blood cell disease which is characterized by deposition of fragments of infectionfighting immunoglobulins, called light chains lcs, in the body.
Aug 02, 2016 light chain deposition disease lcdd is a rare condition characterized by the deposition of specific proteins monoclonal light chains in the kidneys and other organs. The serum free light chain test can be used to determine light chain levels of disease, so patients will want to track their light chain numbers. Kappa light chain multiple myeloma treatment multiple myeloma is a rare form of cancer that begins in the bone marrow, when abnormal plasma cells accumulate and crowd out healthy blood cells. Although most multiple myeloma mm cases are characterized by the detection of a monoclonal immunoglobulin in the serum, about 15% of the patients present only immunoglobulin light chains. Light chain deposition disease genetic and rare diseases. During the 1year period, 7 new cases of light chain multiple myeloma and 22 new cases of other forms of multiple myeloma were diagnosed. The most common type of mprotein found in mm is immunoglobulin igg followed by iga and light chain only. The serum free light chain assay sflca is a blood test that measures the levels of light chains and can be used to. Our practice has a high percentage 55% of abnormal flc ratios in submitted samples, and approximately 0. Measure of disease and treatment response in light chain multiple myeloma patients using urine and serum assays. Multiple myeloma is diagnosed based on the results of clinical tests. He kept going downhill and finally went back to our family doctor who ran a lot of tests. Prognostic value of serum free light chain in multiple myeloma. Imwg guidlines serumfree light chain int myeloma fn.
Clinical analysis of cardiac involvement in 53 patients with multiple myeloma coexistent with light chain amyloidosis. Light chain myeloma sometimes called bence jones myeloma. Lightchain diseasean abortive variant of multiple myeloma. Cure 7 are two different types of light chains called kappa. Multiple myeloma mm, a malignant lymphoproliferative bcell disease characterized by the accumulation of monoclonal plasma cells in the bone marrow, is the second most frequent. Light chain myeloma, also known as light chain disease, is a type of multiple myeloma. He was seeing pain specialists, had kyphoplasty and was getting treatment for spongy muscles. Imwg criteria for the diagnosis of myeloma and guidelines for the diagnostic workup of myeloma criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies that are. Theses recommendations are excerpted from palumbo a et. If the myeloma cells in the bone marrow are secreting lambda free light chains, then the freelite. Sep 26, 2019 light chain deposition disease lcdd is the deposition of monoclonal light chains in multiple organs. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of red blood cells, imaging scans that show tumors, and kidney dysfunction are evidence that doctors use to diagnose myeloma and related disorders. Nonsecretory and light chain escape in patients with multiple.
Light chain myeloma pdf file read online kyrtsonis mc, vassilakopoulos tp, kafasi n, et al. Drabick,1 jozef malysz,2 giampaolo talamo1 abstract multiple myeloma secretes a. Under normal circumstances, these antibodies attach to specific invader antigens and, together with other immune system cells, disable and destroy the antigen andor associated infectious agent or cell. Stage 3 light chain multiple myeloma cancer survivors. There are different stages and varieties of this incurable form of cancer, and each one produces different symptoms and levels of risk to the patients wellbeing and life. Generally, myeloma specialists do not treat patients differently based on their heavy or light chain myeloma type.
Drabick,1 jozef malysz,2 giampaolo talamo1 abstract multiple myeloma secretes a monoclonal protein, either as intact immunoglobulin molecule, or light chain. Imwg criteria for the diagnosis of myeloma and guidelines. Increases in the flc concentration after treatment for mm may be due to a lightchain escape phenomenon, referred to as lightchain escape from plateau phase lepp. Under normal circumstances, these antibodies attach to. Common questions and answers about revlimid and light chain myeloma. This type of myeloma is usually more severe than the classic kind. Healthy blood cells produce antibodies that help to fight infection. About 8 months ago i partially tore a tendon in my my left ankle. Kappa light chain multiple myeloma treatment mercy.
Free light chain results can be converted back and forth in terms of units easily just by dividing or multiplying by 10. It is a rare disease characterized by deposition of nonamyloid immunoglobulin light chains, and they do not stain with congo red and do not exhibit a fibrillar structure when examined ultrastructurally. Serumfree lightchain analysis in diagnosis and management of multiple myeloma and related conditions. I have lambda light chain myeloma and was revlimiddexamethasonevelcade. Avetloiseau h, young p, mathiot c, attal m, harousseau j, bradwell ar, mirbahai l. He was seeing pain specialists, had kyphoplasty and. Imwg criteria for the diagnosis of myeloma and guidelines for. Lightchain myeloma, also known as lightchain disease, is a type of multiple myeloma in which the malignant bone marrow cells produce free monoclonal light chain proteins.
Light chain multiple myeloma, clinic features, responses. An exclusive production of light chains can be found in 15% of myeloma cases. Bottom line in myeloma therapy in patients with multiple myeloma, the free light chain assay is important in predicting response to therapy and for predicting early signs of. Jan 24, 2020 accordingly, the international myeloma working group added a more stringent response category, stringent complete response scr, which in addition to meeting the conventional cr criteria, requires normalization of the serum free light chain sflc ratio and the absence of clonal bone marrow plasma cells bmpcs by either immunohistochemistry. As it progresses, bone pain, bleeding, frequent infections, and anemia may occur. Multiple myeloma mm, also known as plasma cell myeloma and simple myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Quantitation of serum free light chains in combination. Treatment of lightchain deposition disease lcdd is indicated for patients who present with systemic involvement, renal dysfunction, and associated presence of multiple myeloma. Kidney therapy for free light chain removal in patients with.
Hyperviscosity syndrome in association with kappa light. For the more than 3% of myeloma patients who have nonsecretory or oligosecretory disease, and for the majority of patients with al amyloidosis al, the traditional methods of measuring circulating monoclonal immunoglobulins electrophoresis. The kappa and lambda range in the free light chain are a little out of range, but have remained about the same since the first test was done. The treatment brought my counts down to almost normal so i was given cytoxan for good measure and then had my stem cells collected. Original study nonsecretory and light chain escape in patients with multiple myeloma urmeel h. Dec 10, 2019 light chain myeloma pdf file read online kyrtsonis mc, vassilakopoulos tp, kafasi n, et al. The combination of spe and sflc measurements detected 95% of all patients 38 of 40 with any form of multiple myeloma, waldenstrom macroglobulinemia, or primary amyloidosis. This study will evaluate patients with multiple myeloma and severe renal failure treated with kidney therapy previously called supra hfr to remove free light. We report three cases of light chain escape lce at a single institution in poland, including an interesting case of biclonal monoclonal gammopathy of undetermined significance mgus that satisfied the criteria for progression to light chain multiple myeloma lcmm with a rapid rise in serum free light chain flc levels, following steroidal treatment for simultaneous temporal.
Monoclonal gammopathy of undetermined significance mgus facts normal plasma cells a type of white blood cell produce antibodies also known as. Sharply increased serum free lightchain concentrations after. There are 2 types of light chains called kappa and lambda. It is characterised by a clonal population of bone marrow plasma cells which secrete a monoclonal paraprotein or an immunoglobulin free light chain flc figure 1a, b. Quantitation of serum free light chains in combination with. There is research showing that lambda myeloma may be higher risk than kappa myeloma. Multiple myeloma early detection, diagnosis, and staging. Renal failure, bone disease and amyloidosis appear to be more frequent in these patients. Clinical analysis of cardiac involvement in 53 patients with multiple myeloma coexistent with light chain amyloidosis yuanyuan yu, zhongxia huang, wanli hu, xin li, man shen, jiajia zhang, ran tang, shilun chen, wenming chen. Imwg guidelines for serum free light chain analysis in multiple myeloma and related disorders1 for the more than 3% of myeloma patients who have nonsecretory or oligosecretory disease, and for the majority of. Multiple myeloma mm, also known as symptomatic plasma cell myeloma, is a plasma cell malignancy.
749 515 587 1042 289 673 1345 1106 1348 1478 186 472 644 884 351 725 1590 204 307 195 729 747 474 1437 1414 1088 880 1284 1082 732 225 388 479 1372 1141 217 305 792 735 1291 533 1144 490